CEP-32496(RXDX-105)
99%
Reagent
Code: #100001
CAS Number
1188910-76-0
blur_circular Chemical Specifications
scatter_plot
Molecular Information
Weight
517.46 g/mol
Formula
C₂₄H₂₂F₃N₅O₅
badge
Registry Numbers
MDL Number
MFCD22124524
inventory_2
Storage & Handling
Storage
-20℃
description Product Description
CEP-32496, also known as RXDX-105, is primarily investigated for its potential in cancer therapy. It functions as a selective inhibitor of RET (Rearranged during Transfection) kinase, which is often implicated in various cancers, including non-small cell lung cancer (NSCLC) and thyroid cancer. By targeting RET mutations and fusions, CEP-32496 aims to disrupt the signaling pathways that drive tumor growth and progression. Its application is particularly significant in patients with RET-altered tumors, where it offers a targeted treatment approach, potentially improving outcomes compared to traditional chemotherapy. Additionally, its role in combination therapies is being explored to enhance efficacy and overcome resistance mechanisms in advanced cancers.
shopping_cart Available Sizes & Pricing
Cart
No products
Subtotal:
0.00
Total
0.00
THB